Redeye has revised its estimates for Modelon following the Q4 2023 report, which showed results somewhat lower than our projections. Nevertheless, we anticipate a rapid acceleration in pace throughout 2024, along with clear steps toward profitability, which are essential.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases